Global institutions, research centers, and organizations focused on the therapeutic use of psychedelics, emphasizing research, clinical trials, and approval processes for their integration into therapies.
1. MAPS (Multidisciplinary Association for Psychedelic Studies)
Focus: Research and advocacy for the medical use of psychedelics and marijuana, including MDMA for PTSD.
2. Imperial College London – Centre for Psychedelic Research
Focus: Neuroscience, psychology of psychedelics for mental health conditions such as depression and anxiety.
3. Johns Hopkins Center for Psychedelic & Consciousness Research
Focus: Research on psilocybin for mood and behavioral disorders.
4. Heffter Research Institute
Focus: Psilocybin research for mental health conditions such as addiction and cancer-related distress.
5. Usona Institute
Focus: Research on psychedelics like psilocybin for depression and related disorders.
6. Center for Psychedelic Therapies & Research – California Institute of Integral Studies (CIIS)
Focus: Psychedelic-assisted therapy training and research.
7. Centre for the Neuroscience of Psychedelics – Massachusetts General Hospital
Focus: How psychedelics like psilocybin impact brain functioning and mental health disorders.
8. Beckley Foundation
Focus: Policy advocacy and scientific research into consciousness and psychedelics for well-being.
9. TIDES (Therapeutic Initiatives in Drug Experience Studies)
Focus: Psychedelic-assisted therapy and awareness.
10. The University of Zurich – Psychedelic Research Group
Focus: Neuroscience of psychedelics, especially their effects on emotions and cognition.
11. Florey Institute – University of Melbourne
Focus: Psychedelic research on mental health and neuropsychiatric conditions.
12. MindMed
Focus: Developing psychedelic-inspired medicines and digital therapeutics for mental health.
13. Awakn Life Sciences
Focus: Psychedelics for addiction treatment, including ketamine-assisted therapies.
14. Cybin
Focus: Development of psychedelic therapeutics for major depressive disorder and anxiety.
15. Field Trip Health
Focus: Psychedelic-enhanced therapy clinics and research.
16. COMPASS Pathways
Focus: Psilocybin therapy for treatment-resistant depression.
17. Oregon Research Institute – Psilocybin Services Initiative
Focus: Legalization and research for therapeutic psilocybin services.
18. Harvard Interdisciplinary Program in Psychedelics
Focus: Clinical, ethical, and scientific dimensions of psychedelic-assisted therapy.
19. The Beckley/Imperial Research Programme
Focus: Collaboration between Beckley Foundation and Imperial College to research psychedelics.
20. The Institute for Love and Time (TILT)
Focus: Psychedelics for palliative care and end-of-life treatment.
21. MAPS Public Benefit Corporation (MAPS PBC)
Focus: Phase 3 clinical trials for MDMA-assisted psychotherapy for PTSD.
22. Banyan Tree Center
Focus: Psychedelic integration and therapy services.
23. University of Basel – Transdisciplinary Psychedelic Research Group
Focus: Psychedelic-assisted therapy and their effects on human psychology and physiology.
24. Emory Healthcare Veterans Program
Focus: Psychedelic-assisted therapy for PTSD in veterans.
25. Synthesis Institute
Focus: Retreats offering legal, guided psychedelic experiences and integration services.
The above list features a selection of key players in psychedelic research and therapy worldwide. These organizations are at the forefront of developing new treatments for mental health conditions through psychedelic compounds.